Global Point-of-Care Infectious Disease Diagnostics & Testing Market Insights and Forecast to 2028

Report ID: 1750020 | Published Date: Jan 2025 | No. of Page: 114 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 HIV POC
        1.2.3 Clostridium difficile POC
        1.2.4 HBV POC
        1.2.5 Pneumonia or Streptococcus associated infections
        1.2.6 Respiratory syncytial virus (RSV) POC
        1.2.7 HPV POC
        1.2.8 Influenza/Flu POC
        1.2.9 Other Infectious Disease POC
    1.3 Market by Application
        1.3.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Home
        1.3.5 Assisted Living Healthcare Facilities
        1.3.6 Laboratories
        1.3.7 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Perspective (2017-2028)
    2.2 Point-of-Care Infectious Disease Diagnostics & Testing Growth Trends by Region
        2.2.1 Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Point-of-Care Infectious Disease Diagnostics & Testing Historic Market Size by Region (2017-2022)
        2.2.3 Point-of-Care Infectious Disease Diagnostics & Testing Forecasted Market Size by Region (2023-2028)
    2.3 Point-of-Care Infectious Disease Diagnostics & Testing Market Dynamics
        2.3.1 Point-of-Care Infectious Disease Diagnostics & Testing Industry Trends
        2.3.2 Point-of-Care Infectious Disease Diagnostics & Testing Market Drivers
        2.3.3 Point-of-Care Infectious Disease Diagnostics & Testing Market Challenges
        2.3.4 Point-of-Care Infectious Disease Diagnostics & Testing Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Point-of-Care Infectious Disease Diagnostics & Testing Players by Revenue
        3.1.1 Global Top Point-of-Care Infectious Disease Diagnostics & Testing Players by Revenue (2017-2022)
        3.1.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Players (2017-2022)
    3.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Point-of-Care Infectious Disease Diagnostics & Testing Revenue
    3.4 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Concentration Ratio
        3.4.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Point-of-Care Infectious Disease Diagnostics & Testing Revenue in 2021
    3.5 Point-of-Care Infectious Disease Diagnostics & Testing Key Players Head office and Area Served
    3.6 Key Players Point-of-Care Infectious Disease Diagnostics & Testing Product Solution and Service
    3.7 Date of Enter into Point-of-Care Infectious Disease Diagnostics & Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Point-of-Care Infectious Disease Diagnostics & Testing Breakdown Data by Type
    4.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Historic Market Size by Type (2017-2022)
    4.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Forecasted Market Size by Type (2023-2028)
5 Point-of-Care Infectious Disease Diagnostics & Testing Breakdown Data by Application
    5.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Historic Market Size by Application (2017-2022)
    5.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size (2017-2028)
    6.2 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type
        6.2.1 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2017-2022)
        6.2.2 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2023-2028)
        6.2.3 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Type (2017-2028)
    6.3 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application
        6.3.1 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2017-2022)
        6.3.2 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2023-2028)
        6.3.3 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Application (2017-2028)
    6.4 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country
        6.4.1 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2017-2022)
        6.4.2 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size (2017-2028)
    7.2 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type
        7.2.1 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2017-2022)
        7.2.2 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2023-2028)
        7.2.3 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Type (2017-2028)
    7.3 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application
        7.3.1 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2017-2022)
        7.3.2 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2023-2028)
        7.3.3 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Application (2017-2028)
    7.4 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country
        7.4.1 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2017-2022)
        7.4.2 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size (2017-2028)
    8.2 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type
        8.2.1 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Type (2017-2028)
    8.3 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application
        8.3.1 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Application (2017-2028)
    8.4 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region
        8.4.1 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size (2017-2028)
    9.2 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type
        9.2.1 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2017-2022)
        9.2.2 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2023-2028)
        9.2.3 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Type (2017-2028)
    9.3 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application
        9.3.1 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2017-2022)
        9.3.2 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2023-2028)
        9.3.3 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Application (2017-2028)
    9.4 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country
        9.4.1 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2017-2022)
        9.4.2 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size (2017-2028)
    10.2 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type
        10.2.1 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Type (2017-2028)
    10.3 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application
        10.3.1 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Application (2017-2028)
    10.4 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country
        10.4.1 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Details
        11.1.2 Abbott Business Overview
        11.1.3 Abbott Point-of-Care Infectious Disease Diagnostics & Testing Introduction
        11.1.4 Abbott Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
        11.1.5 Abbott Recent Developments
    11.2 Thermo Fisher Scientific Inc
        11.2.1 Thermo Fisher Scientific Inc Company Details
        11.2.2 Thermo Fisher Scientific Inc Business Overview
        11.2.3 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Introduction
        11.2.4 Thermo Fisher Scientific Inc Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
        11.2.5 Thermo Fisher Scientific Inc Recent Developments
    11.3 Roche
        11.3.1 Roche Company Details
        11.3.2 Roche Business Overview
        11.3.3 Roche Point-of-Care Infectious Disease Diagnostics & Testing Introduction
        11.3.4 Roche Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
        11.3.5 Roche Recent Developments
    11.4 Siemens Healthineers
        11.4.1 Siemens Healthineers Company Details
        11.4.2 Siemens Healthineers Business Overview
        11.4.3 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Introduction
        11.4.4 Siemens Healthineers Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
        11.4.5 Siemens Healthineers Recent Developments
    11.5 BD & Company
        11.5.1 BD & Company Company Details
        11.5.2 BD & Company Business Overview
        11.5.3 BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Introduction
        11.5.4 BD & Company Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
        11.5.5 BD & Company Recent Developments
    11.6 Chembio Diagnostics Inc.
        11.6.1 Chembio Diagnostics Inc. Company Details
        11.6.2 Chembio Diagnostics Inc. Business Overview
        11.6.3 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Introduction
        11.6.4 Chembio Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
        11.6.5 Chembio Diagnostics Inc. Recent Developments
    11.7 Trinity Biotech
        11.7.1 Trinity Biotech Company Details
        11.7.2 Trinity Biotech Business Overview
        11.7.3 Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Introduction
        11.7.4 Trinity Biotech Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
        11.7.5 Trinity Biotech Recent Developments
    11.8 Cardinal Health
        11.8.1 Cardinal Health Company Details
        11.8.2 Cardinal Health Business Overview
        11.8.3 Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Introduction
        11.8.4 Cardinal Health Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
        11.8.5 Cardinal Health Recent Developments
    11.9 Quest Diagnostics Inc.
        11.9.1 Quest Diagnostics Inc. Company Details
        11.9.2 Quest Diagnostics Inc. Business Overview
        11.9.3 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Introduction
        11.9.4 Quest Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
        11.9.5 Quest Diagnostics Inc. Recent Developments
    11.10 Bio-Rad Labs Inc.
        11.10.1 Bio-Rad Labs Inc. Company Details
        11.10.2 Bio-Rad Labs Inc. Business Overview
        11.10.3 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Introduction
        11.10.4 Bio-Rad Labs Inc. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
        11.10.5 Bio-Rad Labs Inc. Recent Developments
    11.11 bioMérieux SA
        11.11.1 bioMérieux SA Company Details
        11.11.2 bioMérieux SA Business Overview
        11.11.3 bioMérieux SA Point-of-Care Infectious Disease Diagnostics & Testing Introduction
        11.11.4 bioMérieux SA Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
        11.11.5 bioMérieux SA Recent Developments
    11.12 Sight Diagnostics Ltd.
        11.12.1 Sight Diagnostics Ltd. Company Details
        11.12.2 Sight Diagnostics Ltd. Business Overview
        11.12.3 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Introduction
        11.12.4 Sight Diagnostics Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
        11.12.5 Sight Diagnostics Ltd. Recent Developments
    11.13 Gene POC
        11.13.1 Gene POC Company Details
        11.13.2 Gene POC Business Overview
        11.13.3 Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Introduction
        11.13.4 Gene POC Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
        11.13.5 Gene POC Recent Developments
    11.14 Trivitron Healthcare
        11.14.1 Trivitron Healthcare Company Details
        11.14.2 Trivitron Healthcare Business Overview
        11.14.3 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Introduction
        11.14.4 Trivitron Healthcare Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
        11.14.5 Trivitron Healthcare Recent Developments
    11.15 OJ-Bio Ltd.
        11.15.1 OJ-Bio Ltd. Company Details
        11.15.2 OJ-Bio Ltd. Business Overview
        11.15.3 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Introduction
        11.15.4 OJ-Bio Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
        11.15.5 OJ-Bio Ltd. Recent Developments
    11.16 Ortho-Clinical Diagnostics
        11.16.1 Ortho-Clinical Diagnostics Company Details
        11.16.2 Ortho-Clinical Diagnostics Business Overview
        11.16.3 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Introduction
        11.16.4 Ortho-Clinical Diagnostics Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
        11.16.5 Ortho-Clinical Diagnostics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of HIV POC
    Table 3. Key Players of Clostridium difficile POC
    Table 4. Key Players of HBV POC
    Table 5. Key Players of Pneumonia or Streptococcus associated infections
    Table 6. Key Players of Respiratory syncytial virus (RSV) POC
    Table 7. Key Players of HPV POC
    Table 8. Key Players of Influenza/Flu POC
    Table 9. Key Players of Other Infectious Disease POC
    Table 10. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 11. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 12. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 13. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Region (2017-2022)
    Table 14. Global Point-of-Care Infectious Disease Diagnostics & Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 15. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Region (2023-2028)
    Table 16. Point-of-Care Infectious Disease Diagnostics & Testing Market Trends
    Table 17. Point-of-Care Infectious Disease Diagnostics & Testing Market Drivers
    Table 18. Point-of-Care Infectious Disease Diagnostics & Testing Market Challenges
    Table 19. Point-of-Care Infectious Disease Diagnostics & Testing Market Restraints
    Table 20. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Players (2017-2022) & (US$ Million)
    Table 21. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Share by Players (2017-2022)
    Table 22. Global Top Point-of-Care Infectious Disease Diagnostics & Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-Care Infectious Disease Diagnostics & Testing as of 2021)
    Table 23. Ranking of Global Top Point-of-Care Infectious Disease Diagnostics & Testing Companies by Revenue (US$ Million) in 2021
    Table 24. Global 5 Largest Players Market Share by Point-of-Care Infectious Disease Diagnostics & Testing Revenue (CR5 and HHI) & (2017-2022)
    Table 25. Key Players Headquarters and Area Served
    Table 26. Key Players Point-of-Care Infectious Disease Diagnostics & Testing Product Solution and Service
    Table 27. Date of Enter into Point-of-Care Infectious Disease Diagnostics & Testing Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 30. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Type (2017-2022)
    Table 31. Global Point-of-Care Infectious Disease Diagnostics & Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 32. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Type (2023-2028)
    Table 33. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 34. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Share by Application (2017-2022)
    Table 35. Global Point-of-Care Infectious Disease Diagnostics & Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 36. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Share by Application (2023-2028)
    Table 37. North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 38. North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 39. North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 40. North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 41. North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 42. North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 48. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Asia Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Asia Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Asia Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 54. Asia Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region (2023-2028) & (US$ Million)
    Table 55. Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 63. Middle East and Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 64. Middle East and Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 65. Middle East and Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 66. Middle East and Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 67. Abbott Company Details
    Table 68. Abbott Business Overview
    Table 69. Abbott Point-of-Care Infectious Disease Diagnostics & Testing Product
    Table 70. Abbott Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022) & (US$ Million)
    Table 71. Abbott Recent Developments
    Table 72. Thermo Fisher Scientific Inc Company Details
    Table 73. Thermo Fisher Scientific Inc Business Overview
    Table 74. Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Product
    Table 75. Thermo Fisher Scientific Inc Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022) & (US$ Million)
    Table 76. Thermo Fisher Scientific Inc Recent Developments
    Table 77. Roche Company Details
    Table 78. Roche Business Overview
    Table 79. Roche Point-of-Care Infectious Disease Diagnostics & Testing Product
    Table 80. Roche Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022) & (US$ Million)
    Table 81. Roche Recent Developments
    Table 82. Siemens Healthineers Company Details
    Table 83. Siemens Healthineers Business Overview
    Table 84. Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Product
    Table 85. Siemens Healthineers Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022) & (US$ Million)
    Table 86. Siemens Healthineers Recent Developments
    Table 87. BD & Company Company Details
    Table 88. BD & Company Business Overview
    Table 89. BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Product
    Table 90. BD & Company Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022) & (US$ Million)
    Table 91. BD & Company Recent Developments
    Table 92. Chembio Diagnostics Inc. Company Details
    Table 93. Chembio Diagnostics Inc. Business Overview
    Table 94. Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product
    Table 95. Chembio Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022) & (US$ Million)
    Table 96. Chembio Diagnostics Inc. Recent Developments
    Table 97. Trinity Biotech Company Details
    Table 98. Trinity Biotech Business Overview
    Table 99. Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Product
    Table 100. Trinity Biotech Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022) & (US$ Million)
    Table 101. Trinity Biotech Recent Developments
    Table 102. Cardinal Health Company Details
    Table 103. Cardinal Health Business Overview
    Table 104. Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Product
    Table 105. Cardinal Health Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022) & (US$ Million)
    Table 106. Cardinal Health Recent Developments
    Table 107. Quest Diagnostics Inc. Company Details
    Table 108. Quest Diagnostics Inc. Business Overview
    Table 109. Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product
    Table 110. Quest Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022) & (US$ Million)
    Table 111. Quest Diagnostics Inc. Recent Developments
    Table 112. Bio-Rad Labs Inc. Company Details
    Table 113. Bio-Rad Labs Inc. Business Overview
    Table 114. Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product
    Table 115. Bio-Rad Labs Inc. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022) & (US$ Million)
    Table 116. Bio-Rad Labs Inc. Recent Developments
    Table 117. bioMérieux SA Company Details
    Table 118. bioMérieux SA Business Overview
    Table 119. bioMérieux SA Point-of-Care Infectious Disease Diagnostics & Testing Product
    Table 120. bioMérieux SA Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022) & (US$ Million)
    Table 121. bioMérieux SA Recent Developments
    Table 122. Sight Diagnostics Ltd. Company Details
    Table 123. Sight Diagnostics Ltd. Business Overview
    Table 124. Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Product
    Table 125. Sight Diagnostics Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022) & (US$ Million)
    Table 126. Sight Diagnostics Ltd. Recent Developments
    Table 127. Gene POC Company Details
    Table 128. Gene POC Business Overview
    Table 129. Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Product
    Table 130. Gene POC Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022) & (US$ Million)
    Table 131. Gene POC Recent Developments
    Table 132. Trivitron Healthcare Company Details
    Table 133. Trivitron Healthcare Business Overview
    Table 134. Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Product
    Table 135. Trivitron Healthcare Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022) & (US$ Million)
    Table 136. Trivitron Healthcare Recent Developments
    Table 137. OJ-Bio Ltd. Company Details
    Table 138. OJ-Bio Ltd. Business Overview
    Table 139. OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Product
    Table 140. OJ-Bio Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022) & (US$ Million)
    Table 141. OJ-Bio Ltd. Recent Developments
    Table 142. Ortho-Clinical Diagnostics Company Details
    Table 143. Ortho-Clinical Diagnostics Business Overview
    Table 144. Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Product
    Table 145. Ortho-Clinical Diagnostics Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022) & (US$ Million)
    Table 146. Ortho-Clinical Diagnostics Recent Developments
    Table 147. Research Programs/Design for This Report
    Table 148. Key Data Information from Secondary Sources
    Table 149. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Type: 2021 VS 2028
    Figure 2. HIV POC Features
    Figure 3. Clostridium difficile POC Features
    Figure 4. HBV POC Features
    Figure 5. Pneumonia or Streptococcus associated infections Features
    Figure 6. Respiratory syncytial virus (RSV) POC Features
    Figure 7. HPV POC Features
    Figure 8. Influenza/Flu POC Features
    Figure 9. Other Infectious Disease POC Features
    Figure 10. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Application: 2021 VS 2028
    Figure 11. Hospitals Case Studies
    Figure 12. Clinics Case Studies
    Figure 13. Home Case Studies
    Figure 14. Assisted Living Healthcare Facilities Case Studies
    Figure 15. Laboratories Case Studies
    Figure 16. Others Case Studies
    Figure 17. Point-of-Care Infectious Disease Diagnostics & Testing Report Years Considered
    Figure 18. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 19. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 20. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Region: 2021 VS 2028
    Figure 21. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Players in 2021
    Figure 22. Global Top Point-of-Care Infectious Disease Diagnostics & Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-Care Infectious Disease Diagnostics & Testing as of 2021)
    Figure 23. The Top 10 and 5 Players Market Share by Point-of-Care Infectious Disease Diagnostics & Testing Revenue in 2021
    Figure 24. North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 25. North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Type (2017-2028)
    Figure 26. North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Application (2017-2028)
    Figure 27. North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size Share by Country (2017-2028)
    Figure 28. United States Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Canada Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 31. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Type (2017-2028)
    Figure 32. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Application (2017-2028)
    Figure 33. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size Share by Country (2017-2028)
    Figure 34. Germany Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. France Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. U.K. Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Italy Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Russia Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Nordic Countries Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 41. Asia Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Type (2017-2028)
    Figure 42. Asia Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Application (2017-2028)
    Figure 43. Asia Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size Share by Region (2017-2028)
    Figure 44. China Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Japan Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. South Korea Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Southeast Asia Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. India Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Australia Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 50. Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 51. Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Type (2017-2028)
    Figure 52. Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Application (2017-2028)
    Figure 53. Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size Share by Country (2017-2028)
    Figure 54. Mexico Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Brazil Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 57. Middle East and Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Type (2017-2028)
    Figure 58. Middle East and Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size Market Share by Application (2017-2028)
    Figure 59. Middle East and Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size Share by Country (2017-2028)
    Figure 60. Turkey Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 61. Saudi Arabia Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 62. UAE Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 63. Abbott Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
    Figure 64. Thermo Fisher Scientific Inc Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
    Figure 65. Roche Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
    Figure 66. Siemens Healthineers Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
    Figure 67. BD & Company Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
    Figure 68. Chembio Diagnostics Inc. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
    Figure 69. Trinity Biotech Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
    Figure 70. Cardinal Health Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
    Figure 71. Quest Diagnostics Inc. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
    Figure 72. Bio-Rad Labs Inc. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
    Figure 73. bioMérieux SA Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
    Figure 74. Sight Diagnostics Ltd. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
    Figure 75. Gene POC Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
    Figure 76. Trivitron Healthcare Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
    Figure 77. OJ-Bio Ltd. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
    Figure 78. Ortho-Clinical Diagnostics Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2017-2022)
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott
Thermo Fisher Scientific Inc
Roche
Siemens Healthineers
BD & Company
Chembio Diagnostics Inc.
Trinity Biotech
Cardinal Health
Quest Diagnostics Inc.
Bio-Rad Labs Inc.
bioMérieux SA
Sight Diagnostics Ltd.
Gene POC
Trivitron Healthcare
OJ-Bio Ltd.
Ortho-Clinical Diagnostics
Frequently Asked Questions
Point-of-Care Infectious Disease Diagnostics & Testing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Point-of-Care Infectious Disease Diagnostics & Testing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Point-of-Care Infectious Disease Diagnostics & Testing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Cytology Examination

Cytology Examination market is segmented by players, region (country), by Type and by Application ... Read More